Replies to post #394868 on NorthWest Biotherapeutics Inc (NWBO)

[SecureInvest]

They could easily announce TLD anytime before that. Seems like they are going to discuss how to get a drug faster through the process, which would have way more weight if they were well into that process, which means that TLD would have been announced. JMHO

[ATLnsider]

I can not rule it out completely, solely by looking at the title of the talk that NWBio will present. It is possible that we could get the DCVax-L top line data (TLD) and the top tier, peer reviewed medical journal article prior to the ABTA 2021 Annual Conference. It is also possible that we will get TLD days or weeks later after the conference. No one knows for sure at this juncture.

The target audience for the ABTA annual conferences is typically cancer patients and survivors, their families and caregivers, and ABTA contributors and supporters. I do not expect this conference to be a forum suited for releasing or presenting DCVax-L Phase III clinical trial data.

But, I believe the fact that NWBio is sponsoring this conference and they are giving a talk, is a very positive sign that NWBio is optimistic and confident this close to TLD release. I believe NWBio has been unblinded for some time now, and this is a very strong positive signal that the data is positive and the DCVax-L trial was a success.